Product
MG-O-1002
1 clinical trial
1 indication
Indication
Age-related macular degenerationClinical trial
A Phase II Trial to Evaluate the Efficacy and Safety of Topical Ocular MG-O-1002 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)Status: Recruiting, Estimated PCD: 2024-03-01